Summary:
In this podcast, you will hear an executive fireside discussion with Nouhad Husseini, Regeneron Pharmaceuticals, and Allan Shaw, Portage Biotech /Shaw Strategic Capital, LLC from the 2022 Immuno-Oncology 360° Conference regarding Regeneron’s Approach to Strategic Collaborations, Licensing and Business Development.
To learn more about the Immuno-Oncology 360° Summit, please visit IO360Summit.com.
Related Podcasts
View All
Balancing Innovation and Practicality in Immuno-Oncology Dose Selection
ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma
Understanding the Immunological Effects of Radiopharmaceuticals


